Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.20.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Cash flows from operating activities:    
Net loss $ (14,716) $ (9,408)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 154 147
Stock-based compensation 1,265 1,155
License rights expense settled in stock 0 490
Change in fair value of warrant liability (1,489) (3,059)
Operating lease, net of sublease receipts 90 (10)
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets 294 (2,337)
Accounts payable (810) 1,942
Accrued expenses and other current liabilities 565 (1,441)
Net cash used in operating activities (14,647) (12,521)
Cash flows from investing activities:    
Purchase of fixed assets (360) (42)
Net cash used in investing activities (360) (42)
Cash flows from financing activities:    
Proceeds from exercise of stock options 0 5
Proceeds from exercise of warrants 5 1,557
Payment of tax liability for vested restricted stock units (17) 0
Proceeds from sale of common stock, net of issuance costs 17,077 19,292
Net cash provided by financing activities 17,065 20,854
Effect of exchange rate changes on cash and cash equivalents 2 (16)
Net change in cash and cash equivalents 2,060 8,275
Cash and cash equivalents, at beginning of period 10,735 7,134
Cash and cash equivalents, at end of period 12,795 15,409
Supplemental disclosures of cash flow information:    
Cash paid for interest 0 1
Cash paid for taxes 20 15
Research and development expense settled in stock 0 490
Non-cash investing and financing activities:    
Purchases of property and equipment in accounts payable and accrued liabilities $ 316 $ 21